PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
An alkaloid-rich fraction showed significant antibacterial activity against enterotoxigenic Escherichia coli (ETEC) in vitro [PMID:34299422].
Methanolic extract of seeds reduced serum blood glucose levels and increased serum insulin levels in rats [PMID:37228324].
Methanolic extract of seeds reduced serum levels of cholesterol and triglycerides in rats [PMID:37511810].
The isolated alkaloid holanamine showed significant antileishmanial activity against Leishmania donovani by targeting DNA Topoisomerase 1B [PMID:36417798].
Ethanolic extract and ethyl acetate fraction of stem bark demonstrated anthelmintic efficacy against Raillietina spp. in domestic fowl [PMID:37708168].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 32962166 (2020) — Metabolic Diversity and Therapeutic Potential of Holarrhena pubescens: An Important Ethnomedicinal Plant. · Biomolecules
- 2.PMID: 36816055 (2023) — The complete chloroplast genome of Holarrhena pubescens and its phylogenetic analysis. · Mitochondrial DNA. Part B, Resources
- 3.PMID: 37148427 (2023) — MicroRNAs from Holarrhena pubescens stems: Identification by small RNA Sequencing and their Potential Contribution to Human Gene Targets. · Functional & integrative genomics
- 4.PMID: 37708168 (2023) — Anthelmintic efficacy of Holarrhena pubescens against Raillietina spp. of domestic fowl through ultrastructural, histochemical, biochemical and GLCM analysis. · PloS one
- 5.PMID: 25386454 (2014)